A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis
Clinical trial NCT07519070 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07519070
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-05
- Primary completion
- 2028-04-05
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.